Profile data is unavailable for this security.
About the company
Lotus Pharmaceuticals Inc is a company mainly engaged in development, manufacture, and sales of pharmaceuticals. The Company produces crude medicine and drugs in forms of tablets, capsules, granules, eye-drops, and freeze-dried powder injection. The Company's drug development is focused on the treatment of cerebro-cardiovascular disease, asthma, and diabetes. The Company operated in two business segment Wholesales segment and Retail segment. The Company's products include Maixin-valsartan capsules for the treatment of hypertension, Muxineye drops for the treatment of glaucoma and Yipubishan-octreotide Acetate Injection solution for the treatment of gastric ulcers. The Company mainly conducts its businesses in the domestic market and overseas markets.
- Revenue in USD (TTM)70.79m
- Net income in USD1.72m
- Incorporated2004
- Employees233.00
- LocationLotus Pharmaceuticals Inc16 Cheng Zhuang Road, Feng Tai DistrictBEIJING 100071ChinaCHN
- Phone+86 1 063899868
- Fax+86 1 063899867
- Websitehttp://www.lotuspharma.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LakeShore Biopharma Co Ltd | 88.84m | -14.44m | 6.63m | 573.00 | -- | 0.0463 | 0.998 | 0.0746 | -0.7475 | -0.7475 | 4.64 | 3.48 | 0.427 | 0.5001 | 1.30 | 155,046.40 | -6.94 | -- | -15.95 | -- | 82.47 | -- | -16.26 | -- | 0.7452 | -2.63 | 0.453 | -- | 7.24 | -- | 76.93 | -- | -- | -- |
| CV Sciences Inc | 14.37m | -1.48m | 7.18m | 47.00 | -- | 4.66 | -- | 0.4995 | -0.008 | -0.008 | 0.078 | 0.0084 | 1.87 | 1.67 | 34.74 | 305,659.60 | -19.21 | -44.92 | -66.32 | -105.32 | 47.04 | 42.89 | -10.29 | -49.08 | 0.2125 | -2.02 | 0.3829 | -- | -1.87 | -21.80 | -177.18 | -- | -56.43 | -- |
| Tian'an Pharmaceutical Co Ltd | 10.65m | 3.14m | 8.00m | -- | 0.0445 | 0.0097 | 2.20 | 0.7511 | 0.2246 | 0.2246 | 0.7611 | 1.03 | -- | -- | -- | -- | -- | -- | -- | -- | 68.54 | -- | 29.51 | -- | 13.36 | 25.66 | 0.00 | -- | 50.51 | -- | 106.71 | -- | -- | -- |
| Gelteq Ltd | 117.46k | -4.71m | 8.69m | 7.00 | -- | 0.7751 | -- | 73.95 | -0.4993 | -0.4993 | 0.0125 | 1.05 | 0.0078 | -- | 0.5155 | 16,780.32 | -31.47 | -17.38 | -40.60 | -19.16 | -- | -- | -4,011.74 | -4,507.46 | -- | -3.52 | 0.2106 | -- | -- | -- | -87.40 | -- | -- | -- |
| cbdMD Inc | 19.19m | -4.38m | 8.95m | 42.00 | -- | 1.05 | -- | 0.4661 | -3.92 | -3.92 | 4.77 | 0.8104 | 1.83 | 2.83 | 18.96 | -- | -19.44 | -48.27 | -44.42 | -54.99 | 62.37 | 63.95 | -10.63 | -85.60 | 1.20 | -- | 0.00 | -- | -1.50 | -14.45 | 43.21 | -- | -32.56 | -- |
| Cuprina Holdings (Cayman) Ltd | 23.98k | -2.24m | 8.96m | 14.00 | -- | 1.48 | -- | 373.57 | -0.1231 | -0.1231 | 0.0013 | 0.2828 | 0.0049 | 13.39 | 0.7976 | 1,712.73 | -44.56 | -- | -131.50 | -- | -69.27 | -- | -9,194.46 | -- | 3.58 | -306.25 | 0.0244 | -- | -52.05 | -- | -39.39 | -- | -- | -- |
| Biofrontera Inc | 37.17m | -17.57m | 9.44m | 92.00 | -- | -- | -- | 0.2540 | -1.84 | -1.84 | 4.07 | -0.2216 | 2.19 | 2.44 | 9.45 | 403,967.40 | -103.57 | -48.03 | -339.69 | -77.55 | 64.41 | 48.93 | -47.28 | -60.99 | 0.8033 | -47.48 | 2.37 | -- | 9.54 | 7.35 | 11.78 | -- | -35.51 | -- |
| Bon Natural Life Ltd | 18.67m | -1.99m | 9.87m | 96.00 | 18.18 | 0.226 | -- | 0.5286 | 0.088 | 0.088 | 6.74 | 7.08 | 0.2541 | 6.07 | 1.64 | 194,486.40 | -2.79 | 5.82 | -3.97 | 7.86 | 20.77 | 28.53 | -10.98 | 10.83 | 1.61 | -4.44 | 0.1735 | 0.00 | -21.70 | 0.4899 | -577.58 | -- | 18.20 | -- |
| Integrated Biopharma Inc | 53.43m | 672.00k | 9.94m | 153.00 | 15.10 | 0.4849 | 10.04 | 0.186 | 0.0212 | 0.0212 | 1.71 | 0.6597 | 2.07 | 4.45 | 12.77 | 349,183.00 | 2.60 | 9.98 | 3.28 | 13.68 | 9.75 | 10.74 | 1.26 | 4.58 | 1.92 | -- | 0.0072 | -- | 8.02 | 0.5933 | 482.30 | -30.67 | -0.8556 | -- |
| Lotus Pharmaceuticals Inc | 70.79m | 1.72m | 10.05m | 233.00 | 0.0687 | 0.0011 | 2.60 | 0.142 | 0.0553 | 0.0553 | 2.56 | 3.58 | 0.6321 | 37.27 | 17.85 | 303,836.90 | 1.55 | 22.84 | 1.71 | 26.40 | 35.10 | 41.62 | 2.45 | 19.93 | 0.4428 | 30.80 | 0.0516 | 0.00 | 28.71 | 31.70 | -12.22 | 51.11 | 70.48 | -- |
| Nexgel Inc | 11.67m | -2.88m | 10.50m | 19.00 | -- | 2.03 | -- | 0.9005 | -0.3796 | -0.3796 | 1.53 | 0.6369 | 1.05 | 3.79 | 13.46 | 613,947.40 | -25.14 | -39.08 | -36.83 | -49.79 | 38.30 | 19.60 | -23.91 | -105.40 | 1.08 | -51.36 | 0.1439 | -- | 112.47 | 64.69 | -3.93 | -- | -- | -- |
| Akari Therapeutics PLC (ADR) | 0.00 | -15.77m | 11.35m | 8.00 | -- | -- | -- | -- | -0.600 | -0.600 | 0.00 | -- | 0.00 | -- | -- | 0.00 | -65.57 | -112.46 | -136.47 | -257.78 | -- | -- | -- | -- | -- | -27.77 | 0.0854 | -- | -- | -- | -97.75 | -- | -- | -- |
| Hoth Therapeutics Inc | 0.00 | -12.16m | 13.32m | 2.00 | -- | 1.58 | -- | -- | -1.06 | -1.06 | 0.00 | 0.5442 | 0.00 | -- | -- | 0.00 | -138.61 | -129.47 | -154.67 | -144.30 | -- | -- | -- | -- | -- | -493.48 | 0.00 | -- | -- | -- | -4.37 | -- | -- | -- |
| Cellectar Biosciences Inc | 0.00 | -18.85m | 13.61m | 11.00 | -- | 1.37 | -- | -- | -10.78 | -10.78 | 0.00 | 2.94 | 0.00 | -- | -- | 0.00 | -72.62 | -104.57 | -141.24 | -133.43 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -4.23 | -- | 33.54 | -- |
Data as of Feb 09 2026. Currency figures normalised to Lotus Pharmaceuticals Inc's reporting currency: US Dollar USD
11.93%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Dimensional Fund Advisors Ltd.as of 30 Nov 2025 | 3.32m | 11.93% |
Data from 30 Sep 2025 - 30 Sep 2025Source: FactSet Research Systems Inc.
